Empresa BICYCL Nasdaq
Acciones
US0887861088
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Chemically Synthesized Medicines
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +86,52 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +86,52 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Kevin Lee
CEO | Chief Executive Officer | 55 | 01/09/15 |
Alethia Young
DFI | Director of Finance/CFO | 45 | 17/07/23 |
Alistair Milnes
COO | Chief Operating Officer | 50 | 01/01/21 |
Michael Skynner
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/16 |
Nicholas Keen
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/17 |
David Borah
IRC | Investor Relations Contact | - | 01/04/21 |
Jennifer Perry
PRN | Corporate Officer/Principal | - | - |
Travis Thompson
AUD | Comptroller/Controller/Auditor | - | 01/04/18 |
Zafar Qadir
LAW | General Counsel | - | 23/04/20 |
Santiago Arroyo
PRN | Corporate Officer/Principal | 64 | 31/03/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Pierre Legault
CHM | Chairman | 63 | 18/03/19 |
Director/Board Member | 61 | 17/03/21 | |
Richard Kender
BRD | Director/Board Member | 68 | 24/07/19 |
Janice Bourque
BRD | Director/Board Member | 67 | 18/07/19 |
Gregory Winter
FOU | Founder | 73 | 01/01/09 |
Kevin Lee
CEO | Chief Executive Officer | 55 | 01/09/15 |
Stephen Sands
BRD | Director/Board Member | 67 | 20/02 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 37 880 303 | 4 333 333 ( 11,44 %) | 0 | 11,44 % |
Información de la empresa
Bicycle Therapeutics Plc
Granta Park Great Abington Portway Building
CB21 6GS, Cambridge
+44 1223 261 503
http://bicycletherapeutics.comSector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |